about
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors.Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.Intrinsic Contact Between T and N Classifications in Resected Well-Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms.Electrophoretic cytopathology resolves ERBB2 forms with single-cell resolution.The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genomic landscape of pancreatic neuroendocrine tumors
@ast
Genomic landscape of pancreatic neuroendocrine tumors
@en
Genomic landscape of pancreatic neuroendocrine tumors
@nl
type
label
Genomic landscape of pancreatic neuroendocrine tumors
@ast
Genomic landscape of pancreatic neuroendocrine tumors
@en
Genomic landscape of pancreatic neuroendocrine tumors
@nl
prefLabel
Genomic landscape of pancreatic neuroendocrine tumors
@ast
Genomic landscape of pancreatic neuroendocrine tumors
@en
Genomic landscape of pancreatic neuroendocrine tumors
@nl
P2093
P2860
P1476
Genomic landscape of pancreatic neuroendocrine tumors
@en
P2093
Alfred C Feller
Christian Schmidt-Werthern
Christoph Thorns
Georg Brabant
Hendrik Lehnert
Nehara Begum
Niklas Gebauer
Tobias Keck
Veronica Bernard
P2860
P304
17498-17506
P356
10.3748/WJG.V20.I46.17498
P407
P50
P577
2014-12-01T00:00:00Z